SCHEMBL7306991

SCHEMBL7306991

NCCCn1cnc2cc(C3=NNC(=O)CC3)ccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE3B Q13370 10/20 0.47
▸ PDE3A Q14432 10/20 0.47
▸ PDE2A O00408 1/20 0.47
▸ HRH3 Q9Y5N1 3/20 0.43
▸ MAPT P10636 2/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ LMNA P02545 2/20 0.43
▸ NPY1R P25929 1/20 0.43
▸ NPY2R P49146 1/20 0.43
▸ PDE4A P27815 3/20 0.42
▸ PDE4B Q07343 3/20 0.42
▸ PDE4C Q08493 3/20 0.42
▸ PDE4D Q08499 3/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7299672 0.93 PDE3B (0.48) PDE3BPDE3APDE2AHRH3MAPT
SCHEMBL7295628 0.81 PDE3B (0.46) PDE3BPDE3APDE2AMAPTLMNA
SCHEMBL7306629 0.78 CYP1A2 (0.47) PDE3BPDE3APDE2AHRH3MAPT
SCHEMBL7303295 0.75 PDE3B (0.44) PDE3BPDE3APDE2AHRH3MAPT
SCHEMBL7303102 0.73 PDE3B (0.43) PDE3BPDE3APDE2AMAPTPDE4A
SCHEMBL7295569 0.73 PDE3B (0.45) PDE3BPDE3APDE2AMAPTLMNA
SCHEMBL7307403 0.72 PDE3B (0.50) PDE3BPDE3AHRH3MAPTPDE4A
SCHEMBL7275413 0.71 PDE3B (0.47) PDE3BPDE3APDE2AMAPTLMNA
SCHEMBL4903296 0.70 PDE3B (0.54) PDE3BPDE3AHRH3MAPTLMNA
SCHEMBL9877849 0.70 PDE3B (0.43) PDE3BPDE3AMAPTLMNANPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5135932-A 2-HYDROXYPROPYLAMINO-ALKYL-BENZIMIDAZOLY-5-YL DERIVATIVES AND THEIR USE IN THE TREATMENT OF HEART DISEASE DR. KARL THOMAE GMBH (DE) 1992-08-04 — — US disclosed
EP-0400519-A1 2-Hydroxy-n-propylamines, medicaments containing these compounds and method for preparing them Dr. Karl Thomae GmbH (DE) 1990-12-05 — — EP disclosed
Send feedback